Compound Summary
Compound Information
CEPHAPIRIN SODIUM
Compound Name: | CEPHAPIRIN SODIUM |
Compound CID: | 23675312 |
Synonyms: | CEPHAPIRIN SODIUM cefapirin sodium 24356-60-3 Sodium cefapirin Cefadyl More... |
Iupac Name: | sodium;(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
InChI: | InChI=1S/C17H17N3O6S2.Na/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11;/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25);/q;+1/p-1/t13-,16-;/m1./s1 |
InChIKey: | VGEOUKPOQQEQSX-OALZAMAHSA-M |
Canonical Smiles: | CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)[O-].[Na+] |
Isomeric Smiles: | CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)[O-].[Na+] |
Molecular Weight: | 445.4 |
Molecular Formula: | C17H16N3NaO6S2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
CEPHAPIRIN SODIUM
Molecular Weight: | 445.4 |
Molecular Formula: | C17H16N3NaO6S2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 9 |
Rotatable Bond Count: | 8 |
Heavy Atom Count: | 29 |
Complexity: | 713 |
Synonyms
CEPHAPIRIN SODIUM
| CEPHAPIRIN SODIUM | CEPHAPIRIN SODIUM |
|---|---|
CEPHAPIRIN SODIUM |
cefapirin sodium |
24356-60-3 |
Sodium cefapirin |
Cefadyl |
UNII-431LFF7I7J |
Cefatrexyl |
Ambrocef |
Cefatrex |
Cefapirin sodium salt |
Sodium cephapirin |
BL-P 1322 |
Cefaloject |
Sodium 7-(pyrid-4-ylthioacetamido)cephalosporanate |
Cephapirin sodium salt |
431LFF7I7J |
CHEBI:3545 |
Cephatrexil |
Cefa lak |
Brisfirina |
BLP 1322 |
Cela-Lak/ToDay |
DSSTox_CID_25574 |
DSSTox_RID_80971 |
DSSTox_GSID_45574 |
Cephatrexyl |
Brisporin |
Bristocef |
Cefapirina sodica |
Cefadyl IM/IV |
(7R,7aR)-3-(acetyloxymethyl)-6-oxo-7-(2-(4-pyridylthio)acetylamino)-2H,7H-azet idino2,1-b1,3-thiazine-4-carboxylic acid, sodium salt |
Sodium (6R,7R)-3-(acetoxymethyl)-8-oxo-7-(2-(pyridin-4-ylthio)acetamido)-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylate |
Sodium (6R-trans)-3-(acetoxymethyl)-8-oxo-7-((4-pyridylthio)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate |
Sodium (6R-trans)-3-(acetoxymethyl)-8-oxo-7-(4-pyridylthio)acetamido-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylate |
Cefa-Lak (Veterinary) |
Antibiotic BL-P 1322 |
356C603 |
Cephapirin sodium USAN:USP |
Prestwick_27 |
NCGC00017093-01 |
Cefadyl (TN) |
EINECS 246-194-2 |
CAS-24356-60-3 |
NSC 179171 |
Cefapirin sodium (JAN) |
7-(alpha-(4-Pyridylthio)acetamido)cephalosporanic acid sodium salt |
Cephapirin sodium (USP) |
Cephapirin sodium, >=96% |
SCHEMBL64430 |
SPECTRUM1500167 |
CHEMBL1201043 |
DTXSID7045574 |
HMS500C04 |
HMS1570L03 |
HMS1920K13 |
HMS2091A16 |
sodium;(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-(2-pyridin-4-ylsulfanylacetyl)amino-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylate |
Tox21_110772 |
BL-P-1322 |
CCG-38912 |
Cefapirin sodium, analytical standard |
AKOS024282660 |
Tox21_110772_1 |
NCGC00093735-01 |
NCGC00162116-04 |
3-(Acetyloxy)methyl-8-oxo-7-{(4-pyridinylthio)acetylamino}-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid monosodium salt |
Monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetate (ester) |
ST057376 |
EU-0100279 |
C 8270 |
C08101 |
C74249 |
D00908 |
A924266 |
Q27106128 |
Cefapirin sodium, European Pharmacopoeia (EP) Reference Standard |
Cephapirin sodium, United States Pharmacopeia (USP) Reference Standard |
(6R,7R)-3-(Acetyloxy)methyl-8-oxo-7-(4-pyridinylthio)acetylamino-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid sodium |
5-Thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-, acetate (ester), monosodium salt |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-(((4-pyridylthio)acetyl)amino)-, monosodium salt, (6R-trans)- |
monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetate |
sodium (6R,7R)-3-(acetyloxy)methyl-8-oxo-7-{(pyridin-4-ylsulfanyl)acetylamino}-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylate |
Experimental Data
CEPHAPIRIN SODIUM
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 5 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
CEPHAPIRIN SODIUM
Statistics Data
CEPHAPIRIN SODIUM
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 5 | 1 | 1 |
Statistics Data Visualization
CEPHAPIRIN SODIUM
